These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 23866958)
1. Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasis. Taylor MJ; Hoerauf A; Townson S; Slatko BE; Ward SA Parasitology; 2014 Jan; 141(1):119-27. PubMed ID: 23866958 [TBL] [Abstract][Full Text] [Related]
2. Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis. Aljayyoussi G; Tyrer HE; Ford L; Sjoberg H; Pionnier N; Waterhouse D; Davies J; Gamble J; Metuge H; Cook DAN; Steven A; Sharma R; Guimaraes AF; Clare RH; Cassidy A; Johnston KL; Myhill L; Hayward L; Wanji S; Turner JD; Taylor MJ; Ward SA Sci Rep; 2017 Mar; 7(1):210. PubMed ID: 28303006 [TBL] [Abstract][Full Text] [Related]
3. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis. Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363 [TBL] [Abstract][Full Text] [Related]
4. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial. Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054 [TBL] [Abstract][Full Text] [Related]
5. Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activity. von Geldern TW; Morton HE; Clark RF; Brown BS; Johnston KL; Ford L; Specht S; Carr RA; Stolarik DF; Ma J; Rieser MJ; Struever D; Frohberger SJ; Koschel M; Ehrens A; Turner JD; Hübner MP; Hoerauf A; Taylor MJ; Ward SA; Marsh K; Kempf DJ PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007159. PubMed ID: 30818326 [TBL] [Abstract][Full Text] [Related]
6. Anti- Wan Sulaiman WA; Kamtchum-Tatuene J; Mohamed MH; Ramachandran V; Ching SM; Sazlly Lim SM; Hashim HZ; Inche Mat LN; Hoo FK; Basri H Indian J Med Res; 2019 Jun; 149(6):706-714. PubMed ID: 31496523 [TBL] [Abstract][Full Text] [Related]
7. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns. Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363 [TBL] [Abstract][Full Text] [Related]
8. Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Hoerauf A; Mand S; Fischer K; Kruppa T; Marfo-Debrekyei Y; Debrah AY; Pfarr KM; Adjei O; Büttner DW Med Microbiol Immunol; 2003 Nov; 192(4):211-6. PubMed ID: 12684759 [TBL] [Abstract][Full Text] [Related]
9. Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study. Hoerauf A; Specht S; Büttner M; Pfarr K; Mand S; Fimmers R; Marfo-Debrekyei Y; Konadu P; Debrah AY; Bandi C; Brattig N; Albers A; Larbi J; Batsa L; Taylor MJ; Adjei O; Büttner DW Med Microbiol Immunol; 2008 Sep; 197(3):295-311. PubMed ID: 17999080 [TBL] [Abstract][Full Text] [Related]
10. Filariasis in Africa--treatment challenges and prospects. Hoerauf A; Pfarr K; Mand S; Debrah AY; Specht S Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis. Clare RH; Cook DA; Johnston KL; Ford L; Ward SA; Taylor MJ J Biomol Screen; 2015 Jan; 20(1):64-9. PubMed ID: 25278497 [TBL] [Abstract][Full Text] [Related]
12. Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial. Debrah AY; Specht S; Klarmann-Schulz U; Batsa L; Mand S; Marfo-Debrekyei Y; Fimmers R; Dubben B; Kwarteng A; Osei-Atweneboana M; Boakye D; Ricchiuto A; Büttner M; Adjei O; Mackenzie CD; Hoerauf A Clin Infect Dis; 2015 Aug; 61(4):517-26. PubMed ID: 25948064 [TBL] [Abstract][Full Text] [Related]
13. Anti-Wolbachia drugs for filariasis. Johnston KL; Hong WD; Turner JD; O'Neill PM; Ward SA; Taylor MJ Trends Parasitol; 2021 Dec; 37(12):1068-1081. PubMed ID: 34229954 [TBL] [Abstract][Full Text] [Related]
14. Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis. Sharma R; Al Jayoussi G; Tyrer HE; Gamble J; Hayward L; Guimaraes AF; Davies J; Waterhouse D; Cook DA; Myhill LJ; Clare RH; Cassidy A; Steven A; Johnston KL; Ford L; Turner JD; Ward SA; Taylor MJ Sci Rep; 2016 Mar; 6():23458. PubMed ID: 26996237 [TBL] [Abstract][Full Text] [Related]
15. A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis. Halliday A; Guimaraes AF; Tyrer HE; Metuge HM; Patrick CN; Arnaud KO; Kwenti TD; Forsbrook G; Steven A; Cook D; Enyong P; Wanji S; Taylor MJ; Turner JD Parasit Vectors; 2014 Oct; 7():472. PubMed ID: 25338621 [TBL] [Abstract][Full Text] [Related]
16. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. Mackenzie CD; Geary TG Expert Rev Anti Infect Ther; 2011 May; 9(5):497-501. PubMed ID: 21609260 [No Abstract] [Full Text] [Related]